Arctic Bioscience AS (OSL:ABS)
2.850
-0.010 (-0.35%)
May 13, 2025, 1:22 PM CET
Arctic Bioscience AS Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Cash & Equivalents | 3.28 | 79.6 | 144.15 | 227.36 | 12.6 | Upgrade
|
Cash & Short-Term Investments | 3.28 | 79.6 | 144.15 | 227.36 | 12.6 | Upgrade
|
Cash Growth | -95.88% | -44.78% | -36.60% | 1704.45% | -46.18% | Upgrade
|
Accounts Receivable | 14.57 | 9.57 | 13.48 | 7.7 | 11.01 | Upgrade
|
Other Receivables | 11.05 | 11.19 | 5.24 | 3.34 | 2.78 | Upgrade
|
Receivables | 25.62 | 20.76 | 18.71 | 11.05 | 13.78 | Upgrade
|
Inventory | 28.99 | 32.79 | 35.46 | 28.53 | 26.25 | Upgrade
|
Total Current Assets | 57.89 | 133.15 | 198.33 | 266.93 | 52.63 | Upgrade
|
Property, Plant & Equipment | 24.47 | 26.44 | 22.33 | 15.99 | 6.36 | Upgrade
|
Goodwill | 1.93 | 2.53 | - | - | - | Upgrade
|
Other Intangible Assets | 1.59 | 1.78 | 2.14 | 2.33 | 2.3 | Upgrade
|
Long-Term Deferred Charges | 193.87 | 136.35 | 104.9 | 56.22 | 31.9 | Upgrade
|
Other Long-Term Assets | 0 | - | -0 | - | - | Upgrade
|
Total Assets | 279.74 | 300.25 | 327.7 | 341.47 | 93.2 | Upgrade
|
Accounts Payable | 18.98 | 18.38 | 18.25 | 8.36 | 9.93 | Upgrade
|
Accrued Expenses | 2.08 | 21.27 | 22.17 | 12.56 | 10.87 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 0 | 1.88 | Upgrade
|
Other Current Liabilities | 46.49 | - | - | -0 | - | Upgrade
|
Total Current Liabilities | 67.54 | 39.65 | 40.42 | 20.92 | 22.68 | Upgrade
|
Long-Term Debt | 1.47 | - | - | - | 6.58 | Upgrade
|
Long-Term Leases | - | 2.05 | - | - | - | Upgrade
|
Total Liabilities | 69.01 | 41.69 | 40.42 | 20.92 | 29.26 | Upgrade
|
Common Stock | 2.54 | 2.54 | 2.44 | 2.43 | 1.29 | Upgrade
|
Additional Paid-In Capital | 208.19 | 256.02 | 284.84 | 318.12 | 40.01 | Upgrade
|
Comprehensive Income & Other | - | - | - | - | 22.64 | Upgrade
|
Shareholders' Equity | 210.73 | 258.56 | 287.28 | 320.55 | 63.94 | Upgrade
|
Total Liabilities & Equity | 279.74 | 300.25 | 327.7 | 341.47 | 93.2 | Upgrade
|
Total Debt | 1.47 | 2.05 | - | 0 | 8.46 | Upgrade
|
Net Cash (Debt) | 1.8 | 77.55 | 144.15 | 227.36 | 4.14 | Upgrade
|
Net Cash Growth | -97.67% | -46.20% | -36.60% | 5385.57% | -74.50% | Upgrade
|
Net Cash Per Share | 0.07 | 3.05 | 5.89 | 9.34 | 0.30 | Upgrade
|
Filing Date Shares Outstanding | 25.44 | 25.37 | 24.46 | 24.3 | 13.88 | Upgrade
|
Total Common Shares Outstanding | 25.44 | 25.37 | 24.46 | 24.3 | 13.88 | Upgrade
|
Working Capital | -9.65 | 93.51 | 157.9 | 246.01 | 29.95 | Upgrade
|
Book Value Per Share | 8.28 | 10.19 | 11.75 | 13.19 | 4.61 | Upgrade
|
Tangible Book Value | 207.21 | 254.25 | 285.14 | 318.23 | 61.63 | Upgrade
|
Tangible Book Value Per Share | 8.15 | 10.02 | 11.66 | 13.10 | 4.44 | Upgrade
|
Buildings | - | - | 20.38 | 14.17 | - | Upgrade
|
Machinery | - | - | 5.17 | 4.08 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.